Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel)
Clinical trial NCT07200089 · RECRUITING
Trial details
- NCT number
- NCT07200089
- Sponsor
- Washington University School of Medicine
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-31
- Primary completion
- 2028-03-10
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.